A Study to Assess the Long-term Safety and Efficacy of ASP1941 in Japanese Diabetic Patients

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 182 participants.

Also called NCT01054092

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 182 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01054092
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Japan (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01054092. Randomized; no masking; primary purpose treatment. Start 2010-01-14 (actual); primary completion 2011-07-22 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study to Assess the Long-term Safety and Efficacy of ASP1941 in Japanese Diabetic Patients
Condition
Type 2 Diabetes Mellitus
Intervention (Drug)
ipragliflozin
Lead sponsor
Astellas Pharma Inc (class: industry)

Record details

Record id
cardio:ct-nct01054092
Content hash
05f32eb7effed2ae90c5ee2f649bbe83eab26e07ac185e9db1933935dabdfbfa